At a glance
ClinicalIndex Comparison RecordN/ACompleted· 240 enrolled
Drug / intervention
Decision aidbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating the Performance of the Shared Decision Making Process Scale in Patients Making Cancer Screening Decisions
In Brief
An observational study evaluating Decision aid for Breast Cancer Screening and 2 related conditions. Completed, enrolled 240 participants across 1 site.
Detailed Summary
The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsAgency for Healthcare Research and Quality (AHRQ)
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartSep 2020
First PostedOct 2020
Primary CompletionApr 2021
Study CompletionJun 2021
TodayJul 2026
First PostedOct 23, 2020
Enrollment StartSep 29, 2020
Primary CompletionApr 16, 2021
Study CompletionJun 24, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.7 years ago
Interventions
Decision aidbehavioral
Healthwise patient decision aids for breast, prostate, colon and lung cancer screening provide information on the pros and cons of cancer screening and guidance in process of selecting a choice.